The undifferentiated thyroid cancer cell line, 8505C, was used due to the high surface level expression of PD-L1 (Cantara et al., 2019) and higher AR expression relative to other thyroid cancer cell lines based on mRNA-sequencing and protein array data in the CCLE (Supplementary Figure 4). The gene discussed is AR; the disease is thyroid cancer.